KENOSHA, WI / ACCESSWIRE / October 1, 2024 / OccuPro, a leader in employment testing software, proudly announces the release ...

Cherwell, cleanroom microbiology solutions expert,  is pleased to announce its participation in the upcoming Pharmaceutical ...

With nearly £2.9 million[1] worth of vaccines lost annually due to cold chain issues, the ongoing need for innovative and ...

DUBAI, UAE / ACCESSWIRE / October 1, 2024 / Patient outcomes are being revolutionized by cutting-edge technologies and ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...

FORT LAUDERDALE, FL, October 1, 2024 (Newswire.com) - Physicians Group, LLC's Network Of Clinics And Diverse Patient ...

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical ...

Original-Research: Formycon AG - from First Berlin Equity Research GmbH01.10.2024 / 17:05 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group AG.The issuer is solely ...

Helios Global Group (“Helios”) has today announced that it has agreed a new investment partnership with Telemos Capital (“Telemos”), a European mid-market private equity firm backed by family capital.

Dr. Sugita – formerly Vice President, Head of R&D for Bristol Myers Squibb in Japan – brings nearly 20 years’ experience in R&D and commercial roles working within the Japanese businesses of global ...

Findings from UK burosumab early access program spotlighted in oral presentation at ASBMR annual meetingStatistically significant improvements seen in patient-reported measures of pain, stiffness, ...

The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP facilities in Italy and US NEW YORK CITY, NY / ACCESSWIRE / ...